SCHEMBL5310319

SCHEMBL5310319

COC(=O)C(F)Cc1cc(Br)c(OCc2cccc(N(S(C)(=O)=O)S(C)(=O)=O)c2Cl)c(Br)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 9/20 0.37
THRB P10828 9/20 0.37
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2C19 P33261 2/20 0.35
FABP4 P15090 1/20 0.34
FABP5 Q01469 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
ALOX12 P18054 1/20 0.33
BLM P54132 1/20 0.33
PLEC Q15149 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CYP2C9 P11712 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ESR1 P03372 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5310318 1.00 THRA (0.37) THRATHRBCYP1A2CYP3A4CYP2D6
SCHEMBL14540664 0.91 THRA (0.40) THRATHRBCYP1A2CYP3A4CYP2D6
SCHEMBL14540614 0.84 THRA (0.38) THRATHRBCYP1A2CYP3A4CYP2D6
SCHEMBL5309606 0.84 THRA (0.38) THRATHRBCYP1A2CYP3A4CYP2D6
SCHEMBL5359578 0.82 THRA (0.41) THRATHRBCYP1A2CYP3A4CYP2D6
SCHEMBL5314974 0.82 THRA (0.41) THRATHRBCYP1A2CYP3A4CYP2D6
SCHEMBL5309978 0.79 THRA (0.39) THRATHRBCYP1A2CYP3A4CYP2D6
SCHEMBL5309388 0.79 THRA (0.39) THRATHRBCYP1A2CYP3A4CYP2D6
SCHEMBL4356784 0.76 THRA (0.40) THRATHRBCYP1A2CYP3A4CYP2D6
SCHEMBL5311039 0.76 THRA (0.40) THRATHRBCYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007039125-A2 AN OPTICALLY ACTIVE THYROID RECEPTOR AGONIST AND OPTICALLY ACTIVE KEY INTERMEDIATES IN ITS PRODUCTION KARO BIO AB (SE) 2007-04-12 WO disclosed